v3.21.2
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Revenue from Contract with Customer [Abstract]        
Product Revenue
Product Cost of Sales
Gross Income
Administrative Expenses 1,640,540 759,216 4,601,853 1,920,109
Research and Development Expenses 2,767,663 908,119 5,437,147 1,435,696
Interest Expense and Debt Discount 1,297,363 701,090 1,661,590
Amortization of Intangible Assets 4,583 13,750
Stock Based Compensation 272,700 287,700
Stock Option Modification Expenses 15,036,051
Loss from Operations (4,408,203) (3,241,981) (25,776,141) (5,318,845)
Other (Income) Expenses        
Interest and Dividend Income (1,714) (135) (7,355) (141)
(Gain)/Loss on Sale of Marketable Securities 1,650 (39,797)
Unrealized Loss on Marketable Securities 298 41,745
Loss on Currency Conversions 758 758
Uninsured Casualty Loss 1,058,086 1,058,086
Gain on Debt Forgiveness (180,257)
Total Other (Income) Expense 1,059,078 (135) 873,180 (141)
Loss Before Income Tax (5,467,281) (3,241,846) (26,649,321) (5,318,704)
Income Tax Benefit
Net Loss $ (5,467,281) $ (3,241,846) $ (26,649,321) $ (5,318,704)
Basic and Diluted loss per common share $ (0.15) $ (0.11) $ (0.78) $ (0.19)
Weighted average basic and diluted common shares outstanding 37,634,747 28,269,692 34,064,914 28,066,574

Source